Hyperkalemia associated with spironolactone therapy
- PMID: 15794020
- PMCID: PMC1472969
Hyperkalemia associated with spironolactone therapy
Comment on
-
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.N Engl J Med. 2004 Aug 5;351(6):543-51. doi: 10.1056/NEJMoa040135. N Engl J Med. 2004. PMID: 15295047
References
-
- American College of Cardiology and American Heart Association. Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: executive summary. 2001. [cited 2005 January 13]. pp. 2101–2113. Available at: http://www.acc.org/clinical/guidelines/failure/exec_summ/I_introduction.htm. - PubMed
-
- Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–717. - PubMed
-
- Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotension-aldosterone system. N Engl J Med. 2004;351:585–592. - PubMed
Publication types
LinkOut - more resources
Full Text Sources